Natco Pharma’s arm enters into settlement agreement with Celgene

10 Jul 2020 Evaluate

Natco Pharma’s subsidiary -- Natco Pharma (Canada) Inc., has entered into a settlement agreement with Celgene (now part of Bristol-Myers Squibb) for the product Lenalidomide Capsules in Canada. The terms of the agreement are confidential as per the agreement.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Natco Pharma Share Price

959.55 22.50 (2.40%)
20-Mar-2026 12:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1773.00
Dr. Reddys Lab 1298.00
Cipla 1257.15
Zydus Lifesciences 890.80
Lupin 2318.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×